Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population
- PMID: 25468486
- DOI: 10.1016/j.trsl.2014.10.008
Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population
Abstract
Retrospective studies suggest that coffee consumption may exert beneficial effects in patients with nonalcoholic fatty liver; however, prospective data supporting a protective role on liver steatosis development are lacking. In this study, we aimed to evaluate the association between coffee consumption and fatty liver onset in the general population. The analysis was performed both in a cross-sectional cohort (n = 347) and, prospectively, in a subcohort of patients without fatty liver at baseline and followed-up for 7 years (n = 147). Fatty liver was diagnosed with abdominal ultrasound and liver steatosis was quantified noninvasively by hepatorenal index (HRI) and SteatoTest, whereas FibroTest was used to assess fibrosis degree. A structured questionnaire on coffee consumption was administrated during a face-to-face interview. Neither the incidence nor the prevalence of fatty liver according to ultrasonography, SteatoTest, and the HRI was associated with coffee consumption. In the cross-sectional study, high coffee consumption was associated with a lower proportion of clinically significant fibrosis ≥ F2 (8.8% vs 16.3%; P = 0.038); consistently, in multivariate logistic regression analysis, high coffee consumption was associated with lower odds for significant fibrosis (odds ratio = 0.49, 95% confidence interval, 0.25-0.97; P = 0.041) and was the strongest predictor for significant fibrosis. No association was demonstrated between coffee consumption and the new onset of nonalcoholic fatty liver, but coffee intake may exert beneficial effects on fibrosis progression.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis.Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596. eCollection 2021. Front Pharmacol. 2021. PMID: 34966282 Free PMC article. Review.
-
The Association Between Coffee Consumption and Nonalcoholic Fatty Liver Disease in the South Korean General Population.Mol Nutr Food Res. 2021 Sep;65(18):e2100356. doi: 10.1002/mnfr.202100356. Epub 2021 Aug 3. Mol Nutr Food Res. 2021. PMID: 34319647
-
Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.Nutrients. 2018 Jan 15;10(1):89. doi: 10.3390/nu10010089. Nutrients. 2018. PMID: 29342916 Free PMC article.
-
Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: The Rotterdam study.J Hepatol. 2017 Aug;67(2):339-348. doi: 10.1016/j.jhep.2017.03.013. Epub 2017 Jun 1. J Hepatol. 2017. PMID: 28578837
-
Coffee and Liver Disease.J Clin Exp Hepatol. 2016 Mar;6(1):40-6. doi: 10.1016/j.jceh.2016.02.003. Epub 2016 Feb 27. J Clin Exp Hepatol. 2016. PMID: 27194895 Free PMC article. Review.
Cited by
-
Food co-consumption network as a new approach to dietary pattern in non-alcoholic fatty liver disease.Sci Rep. 2023 Nov 24;13(1):20703. doi: 10.1038/s41598-023-47752-y. Sci Rep. 2023. PMID: 38001137 Free PMC article.
-
Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review.Nutrients. 2023 Sep 14;15(18):3987. doi: 10.3390/nu15183987. Nutrients. 2023. PMID: 37764771 Free PMC article. Review.
-
Diets with Higher Anti-inflammatory Potential Associated with Lower Risk of Development of Nonalcoholic Fatty Liver Disease and Early-Stage of Fibrosis Among US Adults.Dig Dis Sci. 2023 Oct;68(10):4009-4021. doi: 10.1007/s10620-023-08059-0. Epub 2023 Aug 3. Dig Dis Sci. 2023. PMID: 37535123
-
Crosstalk between dietary patterns, obesity and nonalcoholic fatty liver disease.World J Gastroenterol. 2022 Jul 21;28(27):3314-3333. doi: 10.3748/wjg.v28.i27.3314. World J Gastroenterol. 2022. PMID: 36158263 Free PMC article. Review.
-
Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis.Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596. eCollection 2021. Front Pharmacol. 2021. PMID: 34966282 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous